Immuno-oncology agents continue to transform cancer treatment landscape: GlobalData EP News Bureau May 17, 2023 GlobalData’s latest report, "Thematic Research: Immuno-Oncology” explores the IO pipeline and identifies over 700 novel agents…
Bristol Myers Squibb and bluebird bio get US FDA nod for Abecma (idecabtagene vicleucel) to treat… EP News Bureau Mar 27, 2021 Abecma is a first-in-class BCMA-directed personalised immune cell therapy delivered as a one-time infusion for triple-class…
Bayer, Atara Biotherapeutics to partner for mesothelin-targeted CAR T-cell therapies EP News Bureau Dec 7, 2020 The agreement includes the development candidate ATA3271, an armored allogeneic T-cell immunotherapy, and an autologous version,…
